Medication info
Pevarejet Tablet 4/10 mg

Pevarejet Tablet 4/10 mg

Prescription medicationTabletOral
Ingredient · strength
Pitavastatin Calcium›4mg / 1 tabletEzetimibe›10mg / 1 tablet
Manufacturer / importer
Ankuk Pharmaceutical Co., Ltd.
Appearance
Pink oval film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202301661 · Approved 2023.05.24 · Insurance code 650206030

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
This drug is administered once daily, with or without food. Patients should follow a standard cholesterol-lowering diet continuously before and during treatment with this drug. The dose of this drug should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. The recommended initial dose is 2/10mg once daily. If the LDL cholesterol-lowering effect is insufficient, the dose may be increased to a maximum of 4/10mg daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response. Patients taking pitavastatin calcium and ezetimibe concomitantly may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience. Administration in patients with hepatic impairment: Since the recommended initial dose of pitavastatin calcium in patients with hepatic impairment is 1 milligram daily, use of this drug (pitavastatin calcium/ezetimibe combination) for initial treatment is not recommended. The maximum dose is 2/10mg daily. Use of this drug (pitavastatin calcium/ezetimibe combination) is not recommended in patients with moderate hepatic impairment. Do not administer this drug (pitavastatin calcium/ezetimibe combination) to patients with severe hepatic impairment.

Ingredients

Manufacturer
Ankuk Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL-cholesterol
  • elevated apo B protein
  • elevated triglycerides
  • elevated non-HDL-cholesterol
View approved original text

This medication helps lower the levels of total cholesterol, LDL cholesterol, apo B protein, triglycerides, and non-HDL cholesterol in patients with primary hypercholesterolemia and mixed dyslipidemia. It also has the effect of increasing HDL cholesterol, which is considered good cholesterol. It is used in conjunction with dietary therapy to more effectively improve blood lipid levels.

How to take

Adult dose

This drug is administered once daily, with or without food. Patients should follow a standard cholesterol-lowering diet continuously before and during treatment with this drug. The dose of this drug should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. The recommended initial dose is 2/10mg once daily. If the LDL cholesterol-lowering effect is insufficient, the dose may be increased to a maximum of 4/10mg daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response. Patients taking pitavastatin calcium and ezetimibe concomitantly may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience. Administration in patients with hepatic impairment: Since the recommended initial dose of pitavastatin calcium in patients with hepatic impairment is 1 milligram daily, use of this drug (pitavastatin calcium/ezetimibe combination) for initial treatment is not recommended. The maximum dose is 2/10mg daily. Use of this drug (pitavastatin calcium/ezetimibe combination) is not recommended in patients with moderate hepatic impairment. Do not administer this drug (pitavastatin calcium/ezetimibe combination) to patients with severe hepatic impairment.

Precautions

This medication should not be used in certain patients. It is contraindicated for patients who are allergic to any components of this drug, those with severe liver disease, severe liver dysfunction or bile duct obstruction, patients on cyclosporine, those with myopathy, pregnant women or women who may become pregnant, nursing mothers, and in pediatrics. Caution should be exercised when administering to patients with slightly impaired liver function or those who consume alcohol excessively, patients with renal impairment, patients with hypothyroidism or a history of muscle disorders, elderly patients, and patients with severe muscle weakness. During the use of this medication, various side effects such as muscle pain, weakness, fatigue, indigestion, headache, dizziness, skin rash, and abnormal blood tests may occur. If symptoms occur, consult a physician immediately. Due to the risk of muscle damage, if muscle pain or weakness significantly worsens, discontinue use and consult with healthcare professionals. Regular liver function tests are required before and during treatment due to the possibility of liver function abnormalities. This medication should not be administered to pregnant or breastfeeding women, and women planning to become pregnant must consult with healthcare professionals. This drug may interact with other medications, so any current medications should be disclosed, particularly when taken with cyclosporine, fibrates, niacin, and antibiotics. This medication has not been confirmed for safety and efficacy in children, thus should not be used in this population. In elderly patients, side effects may occur more frequently due to decreased physiological functions, so caution is necessary. In cases of overdose, there is no specific antidote; treatment should be symptomatic, and liver function and muscle-related examinations should be conducted. This medication should be stored out of the reach of children and should not be transferred to another container.

Side effects

  • Abdominal pain
  • diarrhea
  • dry mouth
  • bloating
  • gastroesophageal reflux disease
  • toothache
  • increased serum creatine phosphokinase
  • increased alanine aminotransferase
  • increased aspartate aminotransferase
  • weakness
Show 104 more
  • chest discomfort
  • fatigue
  • myalgia
  • dysgeusia
  • headache
  • urticaria
  • dizziness
  • decreased appetite
  • insomnia
  • shortness of breath
  • constipation
  • xerosis
  • rash
  • pruritus
  • lethargy
  • paralysis
  • thrombocytopenia
  • rigidity
  • drowsiness
  • thirst
  • dyspepsia
  • abdominal distension
  • stomatitis
  • vomiting
  • loss of appetite
  • glossitis
  • nausea
  • upset stomach
  • thrombocytopenia
  • granulocytopenia
  • leukopenia
  • eosinophilia
  • leukocytosis
  • increased globulins
  • anemia
  • polyuria
  • elevated BUN
  • elevated serum creatinine
  • decreased aldosterone
  • increased aldosterone
  • increased adrenocorticotropic hormone
  • increased cortisol
  • decreased testosterone
  • muscle cramps
  • elevated myoglobin
  • palpitations
  • dermalgia
  • burning sensation
  • arthralgia
  • edema
  • blurred vision
  • photophobia
  • hearing loss
  • hematuria
  • elevated uric acid levels
  • increased serum potassium and phosphorus
  • hair loss
  • sleep disorder
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes mellitus
  • immune-mediated necrotizing myopathy
  • facial edema
  • arm edema
  • hypersensitivity
  • skin tingling
  • elevated blood pressure
  • chest discomfort
  • diabetic neuropathy
  • tremors
  • upper abdominal pain
  • dry mouth
  • epigastric discomfort
  • belching
  • gastrointestinal disturbances
  • tongue disorders
  • palpitations
  • congestive heart failure
  • myocardial ischemia
  • flushing
  • cough
  • sputum
  • rhinorrhea
  • limb pain
  • anemia
  • splenomegaly
  • hyperhidrosis
  • cholelithiasis
  • cholecystitis
  • anaphylaxis
  • angioedema
  • erythema multiforme
  • pancreatitis
  • sensory disturbances
  • depression
  • cholelithiasis
  • cholecystitis
  • renal failure
  • liver dysfunction
  • increased serum creatinine
  • increased blood urea nitrogen
  • abnormal liver function tests

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container that protects it from light and at a temperature between 1 degree to 30 degrees Celsius at room temperature. Proper storage preserves the drug's efficacy and safety.

Appearance and packaging

Appearance

Pink oval film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.